P3 8D2 (SCRF 43.1) MOUSE HYBRIDOMA (HB-9169)

Designation / Description P3 8D2 (SCRF 43.1) MOUSE HYBRIDOMA
U.S. Patent Number
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Comments
Animals were immunized with a conjugate of keyhole limpet hemocyanin and a phosphonamidate compound.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody reacts with and catalyzes the hydrolysis of certain ester bonds.
Shipped frozen
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Basic Documentation
References

Lerner RA, et al. Molecules with antibody combining sites that exhibit catalytic properties. US Patent 5,126,258 dated Jun 30 1992